(Q44416304)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12713499%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

title

Treatment of breast cancer in countries with limited resources (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12713499%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

author

Gilberto Schwartsmann

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12713499%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Riccardo Masetti

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12713499%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

author name string

Robert W Carlson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12713499%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Benjamin O Anderson

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12713499%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Rakesh Chopra

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12713499%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Alexandru E Eniu

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12713499%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Raimund Jakesz

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12713499%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Richard R Love

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12713499%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Global Summit Treatment Panel

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12713499%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

language of work or name

1 reference

1 May 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12713499%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12713499%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

9 Suppl 2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12713499%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

S67-74

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12713499%20AND%20SRC:MED&resulttype=core&format=json

Immediate breast reconstruction after mastectomy for cancer

3 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.9.S2.6.X

Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.9.S2.6.X

Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.9.S2.6.X

Oophorectomy and tamoxifen adjuvant therapy in premenopausal Vietnamese and Chinese women with operable breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.9.S2.6.X

Five versus more than five years of tamoxifen for lymph node-negative breast cancer: updated findings from the National Surgical Adjuvant Breast and Bowel Project B-14 randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.9.S2.6.X

Scottish adjuvant tamoxifen trial: a randomized study updated to 15 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.9.S2.6.X

Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.9.S2.6.X

Randomized adjuvant trial of tamoxifen and goserelin versus cyclophosphamide, methotrexate, and fluorouracil: evidence for the superiority of treatment with endocrine blockade in premenopausal patients with hormone-responsive breast cancer--Austrian

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.9.S2.6.X

Adding adjuvant CMF chemotherapy to either radiotherapy or tamoxifen: are all CMFs alike? The International Breast Cancer Study Group (IBCSG).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.9.S2.6.X

Intensive diagnostic follow-up after treatment of primary breast cancer. A randomized trial. National Research Council Project on Breast Cancer follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.9.S2.6.X

Neoadjuvant chemotherapy in breast cancer: significantly enhanced response with docetaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.9.S2.6.X